In Vivo Characterization of an Orally Available, Brain Penetrant Small Molecule GPR139 AgonistBIOLOGICAL PSYCHIATRYIF92018-05-010PREAI
Analysis of Gene Expression in Peripheral Blood Mononuclear Cells in Naive, Depressed-Like, and Stress-Resilient Rodents Reveals Possible Peripheral biomarkers, Correlates with Brain Function, and Possible New Drug Discovery TargetsBIOLOGICAL PSYCHIATRYIF92017-05-010PREAI
Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of InsomniaJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82015-09-0174OAAI
Pharmacology of a Novel Central Nervous System-Penetrant P2X7 Antagonist JNJ-42253432JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82014-12-0166OAAI
Pharmacological or genetic orexin1 receptor inhibition attenuates MK-801 induced glutamate release in mouse cortexFRONTIERS IN NEUROSCIENCEIF3.22014-05-209OAAI
PET Brain Imaging of Neuropeptide Y2 Receptors Using N-11C-Methyl-JNJ-31020028 in PigsJOURNAL OF NUCLEAR MEDICINEIF9.12014-03-1013OAAI
Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567一种新型的可中心渗透的P2X7受体拮抗剂的药理学表征: JNJ-47965567BRITISH JOURNAL OF PHARMACOLOGYIF7.72013-09-17158OA
Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatementPSYCHOPHARMACOLOGYIF3.32010-12-22147PREAI
JNJ-39220675, a novel selective histamine H3 receptor antagonist, reduces the abuse-related effects of alcohol in ratsPSYCHOPHARMACOLOGYIF3.32010-11-1840PREAI
In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y2 receptorPSYCHOPHARMACOLOGYIF3.32009-12-0247PREAI
The effects of thioperamide on extracellular levels of glutamate and GABA in the rat prefrontal cortexPSYCHOPHARMACOLOGYIF3.32009-10-0116PREAI